⚠ RecallRadar📷 ScanGuidesOfficial U.S. recall notices, restated plainly

Ajanta Pharma USA Inc: Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807. NDC: 27

DrugsSource: FDA (drug) · Date: 2026-10-07

Read the official notice at FDA (drug) →

Share on XFacebookRedditEmail

Get alerts for Ajanta Pharma

Guides: Which agency handles which recall (FDA vs USDA vs CPSC vs NHTSA)

The text below is copied from the official FDA (drug) record. If anything differs, the official notice is correct.

Company / brand
Ajanta Pharma USA Inc
Product
Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807. NDC: 27241-126-02
Reason / hazard
Failed Dissolution Specifications: below specification
Classification
Class II
Status
Ongoing
Distribution / sold at
Nationwide in the US.
Recall initiated
2026-09-17
Code info
Lot: DJ25134, Exp 11/30/2028
Voluntary mandated
Voluntary: Firm initiated
City
Bridgewater
State
NJ
Country
United States
Event id
99893
Free daily digest + "My products" watchlist

Get the daily digest, and tell us what to watch. Everything is optional except your email.

Free allergen alerts:

Categories:

Privacy: we store only what you enter here, use it only to send recall alerts you asked for, never sell or share it, and you can unsubscribe anytime. Double opt-in: we will email you a confirmation link before sending anything; alerts start only after you confirm. Every email has unsubscribe and manage-watchlist links.